Efficacy of Intensified Transcranial Direct Current Stimulation in Obsessive-compulsive Disorder
Efficacy of Transcranial Direct Current Stimulation (tDCS) in Symptoms, Quality of Life, Cognitive Deficits and Brain Physiology of Patients With Obsessive-compulsive Disorder
1 other identifier
interventional
42
1 country
1
Brief Summary
This is a randomized, double-blind, parallel-group, sham-controlled trial that aims to investigate the effectiveness of transcranial direct current stimulation (TDCS) on improving symptoms, quality of life, depression, and cognitive functions in 39 patients with obsessive-compulsive disorder (OCD) that are randomized in 3 experimental groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2022
CompletedFirst Submitted
Initial submission to the registry
August 12, 2022
CompletedFirst Posted
Study publicly available on registry
August 15, 2022
CompletedMarch 17, 2026
March 1, 2026
10 months
August 12, 2022
March 15, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Yale-Brown Obsessive-Compulsive (Y-BOCS) rating scale
Score in the Yale-Brown Obsessive-Compulsive (Y-BOCS). Total scores on the measure range from 0 to 40, with a score of 0-7 indicating subclinical symptoms, 8-15 mild symptoms, 16-23 moderate symptoms, 24-31 severe symptoms and 32-40 extreme symptoms.
up to 1 month after the intervention
Beck Anxiety Questionnaire (BAI)
Score in the Beck Anxiety Questionnaire (BAI). The BAI scores are classified as minimal anxiety (0 to 7), mild anxiety (8 to 15), moderate anxiety (16 to 25), and severe anxiety (30 to 63).
up to 1 month after the intervention
Response inhibition task 1
Performance in the response inhibition tasks (Flanker test)
up to 1 month after the intervention
Working memory task
Performance in the working memory task as an executive function task
up to 1 month after the intervention
Response inhibition task 2
Performance in the response inhibition tasks (Go/No-Go task)
up to 1 month after the intervention
Secondary Outcomes (4)
Beck Depression Questionnaire (BDI-II)
up to 1 month after the intervention
Quality of Life Questionnaire (WHOQUL)
up to 1 month after the intervention
electroencephalogram (EEG) oscillatory power
up to 1 month after the intervention
electroencephalogram (EEG) functional connectivity
up to 1 month after the intervention
Study Arms (3)
tDCS group 1
EXPERIMENTALIn the first experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 1 mA electrical stimulation on 5 consecutive days with two sessions per day.
tDCS group 2
EXPERIMENTALIn the second experimental group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of 2 mA electrical stimulation on 5 consecutive days with two sessions per day.
Control group
PLACEBO COMPARATORIn the placebo group, the TDCS intervention protocol consists of 10 sessions of 20 minutes of sham electrical stimulation on 5 consecutive days with two sessions per day.
Interventions
Patients will receive 10 sessions of 20 minutes of either 1 mA, 2 mA or sham electrical stimulation on 5 consecutive days
Eligibility Criteria
You may qualify if:
- Diagnosis of Obsessive-compulsive Disorder by a psychiatrist and DSM-5-based behavioral checklist
- being 18-50 years old
- providing written informed consent
- If female, negative urine pregnancy test
- stable medication regime especially the classical neuroleptics and all CNS-activating medications, if taken, 4-6 weeks before the experiment and during the experiment
You may not qualify if:
- smoker
- pregnancy
- alcohol or substance dependence
- history of seizure
- history of neurological disorder
- history of head injury
- presence of ferromagnetic objects in the body that are contraindicated for brain stimulation of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ardabil University of Medical Sciences
Ardabil, Iran
Related Publications (1)
Alizadehgoradel J, Molaei B, Barzegar Jalali K, Pouresmali A, Sharifi K, Hallajian AH, Nejati V, Glinski B, Vicario CM, Nitsche MA, Salehinejad MA. Targeting the prefrontal-supplementary motor network in obsessive-compulsive disorder with intensified electrical stimulation in two dosages: a randomized, controlled trial. Transl Psychiatry. 2024 Feb 5;14(1):78. doi: 10.1038/s41398-024-02736-y.
PMID: 38316750RESULT
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 12, 2022
First Posted
August 15, 2022
Study Start
August 1, 2020
Primary Completion
June 1, 2021
Study Completion
February 25, 2022
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share